Back to Search Start Over

Machine Learning to Predict Mortality and Critical Events in COVID-19 Positive New York City Patients

Authors :
Robert Freeman
Nidhi Naik
Anuradha Lala
Girish N. Nadkarni
Samuel J. Lee
Jagat Narula
Allan C. Just
Jessica K De Freitas
Andrew Kasarskis
Erwin P. Bottinger
Edgar Argulian
Dennis S. Charney
Akhil Vaid
Kipp W. Johnson
Adam Russak
Paul F. O'Reilly
Eddye Golden
Judith A. Aberg
Patricia Glowe
Carlos Cordon-Cardo
Fayzan Chaudhry
David Reich
Ishan Paranjpe
Kodi B. Arfer
Judy H. Cho
Alexander W. Charney
Valentin Fuster
Benjamin S. Glicksberg
Matteo Danieletto
Barbara Murphy
Arash Kia
Manbir Singh
Laura H Huckins
Bethany Percha
Manish Paranjpe
Carol R. Horowitz
Eric J. Nestler
Sulaiman Somani
Prem Timsina
Riccardo Miotto
Dara Meyer
Eric E. Schadt
Matthew A. Levin
Shan Zhao
Noam D. Beckmann
Zahi A. Fayad
Joseph Finkelstein
Emilia Bagiella
Patricia Kovatch
Publication Year :
2020
Publisher :
Cold Spring Harbor Laboratory, 2020.

Abstract

Coronavirus 2019 (COVID-19), caused by the SARS-CoV-2 virus, has become the deadliest pandemic in modern history, reaching nearly every country worldwide and overwhelming healthcare institutions. As of April 20, there have been more than 2.4 million confirmed cases with over 160,000 deaths. Extreme case surges coupled with challenges in forecasting the clinical course of affected patients have necessitated thoughtful resource allocation and early identification of high-risk patients. However, effective methods for achieving this are lacking. In this paper, we use electronic health records from over 3,055 New York City confirmed COVID-19 positive patients across five hospitals in the Mount Sinai Health System and present a decision tree-based machine learning model for predicting in-hospital mortality and critical events. This model is first trained on patients from a single hospital and then externally validated on patients from four other hospitals. We achieve strong performance, notably predicting mortality at 1 week with an AUC-ROC of 0.84. Finally, we establish model interpretability by calculating SHAP scores to identify decisive features, including age, inflammatory markers (procalcitonin and LDH), and coagulation parameters (PT, PTT, D-Dimer). To our knowledge, this is one of the first models with external validation to both predict outcomes in COVID-19 patients with strong validation performance and identify key contributors in outcome prediction that may assist clinicians in making effective patient management decisions.One-Sentence SummaryWe identify clinical features that robustly predict mortality and critical events in a large cohort of COVID-19 positive patients in New York City.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....42a052788fabfac7506a78b9ce81e5a0
Full Text :
https://doi.org/10.1101/2020.04.26.20073411